跳至主要内容
临床试验/NCT01459263
NCT01459263已完成不适用

Mechanochemical Endovenous Ablation of Great Saphenous Vein Incompetence Using the ClariVeinTM Device: a Prospective Study

Rijnstate Hospital2 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
124
试验地点
2
主要终点
Occlusion rate

研究概览

简要总结

More than 25 percent of the general population suffers from varicose veins, which has a considerable impact on quality of life. Nowadays endovenous treatment modalities for great saphenous incompetence are widely accepted. Mechanochemical endovenous ablation is a new tumescent-less technique, that combines mechanical endothelial damage using a rotating wire with the infusion of a liquid sclerosant. The current study aims at evaluating short and long term outcome after mechanochemical endovenous ablation.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Insufficiency of the GSV
  • Ultrasound criteria for endovenous treatment have been met:
  • Diameter GSV between 3-12 mm
  • No thrombus present at the GSV part to be treated
  • Signed informed consent
  • Patient willing to present at follow-up visits
  • Age > 18 jaar

排除标准

  • Patient is unable to give informed consent
  • Patient unable to present at all follow-up visits
  • Other treatment is more suitable for the treatment of the varicose veins than mechano-chemical ablation
  • Pregnancy and breast feeding
  • Known allergy/ contra indication for sclerotherapy
  • Previous ipsilateral surgical treatment of varicose veins
  • Deep venous vein thrombosis in medical history
  • Anticoagulant therapy

结局指标

主要结局

Occlusion rate

时间窗: 30 days, 1, 2, and 5 years

The percentage of GSV occluded

次要结局

  • Disease related quality of life(30 days, 1, 2, and 5 years)
  • Pain score during procedure(peri-procedural)
  • procedural complications(during procedure)
  • Health status(30 days, 1, 2, and 5 years)
  • 2-weeks post-procedure pain score(two weeks)
  • post-procedural complications(1 year)
  • recovery time(two weeks)

研究者

发起方
Rijnstate Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Michel Reijnen

MD, PhD

Rijnstate Hospital

研究点 (2)

Loading locations...

相似试验